Material Agreements

Keurig Dr Pepper Inc. amended Amendment to Preferred Investment Agreement with KKR Investor, Apollo Investor and other Preferred Investors valued at Company agreed to issue and sell 4,500,000 shares of Series A Convertible Perpetual Preferred Stock (effective 2026-02-23).

“On February 23, 2026, KDP entered into an Amendment (the “ Amendment to Preferred Investment Agreement ”) to the Investment Agreement, dated as of October 27, 2025 (as amended, the “ Preferred Investment Agreement ”), by and among the Company, Pour Purchaser L.P. (together with its affiliates, the “ KKR Investor ”), AP Pour Holdings, L.P. (together with its affiliates, the “ Apollo Investor ”) and certain other investors party thereto (collectively with any other investor that becomes a party thereto, the “ Preferred Investors ”), pursuant to which the Company agreed to issue and sell to the Preferred Investors, and the Preferred Investors agreed to purchase from the Company, 4,500,000 shares of a new series of Series A Convertible Perpetual Preferred Stock, par value $0.01 per share (the “ Convertible Preferred Stock ”), of KDP for a purchase price per share of $1,000 and an aggregate purcha”

Keurig Dr Pepper Inc. entered into Transaction Agreement with Apollo Global Management, Inc., KKR & Co. Inc. and Goldman Sachs Asset Management, L.P. valued at JV Investor Partner will make a capital contribution of $4.0 billion for 49% interest; KDP to retain (effective 2026-02-23).

“On February 23, 2026, KDP entered into a Transaction Agreement (the “ Transaction Agreement ”) by and among the Company, Keurig JV, LP, a Delaware limited partnership (the “ Pod Manufacturing JV ”), Keurig Green Mountain, Inc., a Delaware corporation (“ KGM ”), KGM Manufacturing LLC, a Delaware limited liability company (“ KGMM ”), Keurig Production Holding, LLC, a Delaware limited liability company (“ Keurig USA Partner ”), a Luxembourg private limited liability company to be designated that is a wholly owned subsidiary of the Company (“ Keurig Lux Partner ” and, together with the Company, KGM, KGMM and Keurig USA Partner, the “ Keurig Partners ”), and an investment vehicle (the “ JV Investor Partner ”) held and managed by certain funds or accounts managed, advised or sub-advised by each of Apollo Global Management, Inc., KKR & Co. Inc. and Goldman Sachs Asset Management, L.P.”

Fortress Biotech, Inc. amended Second Amendment to Credit Agreement with Oaktree Fund Administration, LLC valued at Amended credit agreement dated July 25, 2024; $35.0 million initial borrowing, up to $15.0 million a (effective 2026-02-22).

“On February 22, 2026, the Company, as borrower, entered into the Second Amendment to Credit Agreement (the “ Second Amendment ”), which amends that certain Credit Agreement dated July 25, 2024 (the “ Original Agreement ”) with Oaktree Fund Administration, LLC, as the administrative agent (in such capacity, the “ Agent ”), and the lenders from time to time party thereto (as amended by that certain First Amendment to Credit Agreement dated December 12, 2025, collectively with the Original Agreement and the Second Amendment, the “ Loan Agreement ”).”

Fortress Biotech, Inc. entered into Priority Review Voucher Asset Purchase Agreement with Cyprium Therapeutics, Inc. valued at $205 million (effective 2026-02-22).

“On February 22, 2026, Cyprium Therapeutics, Inc. (“Cyprium”), a majority-owned subsidiary of Fortress Biotech, Inc. (the “ Company ”), entered into a definitive asset purchase agreement (the “ PRV APA ”) pursuant to which Cyprium agreed to sell a Rare Pediatric Disease Priority Review Voucher (“ PRV ”).”

Verisk Analytics, Inc. entered into ASR Agreements with HSBC Bank USA, National Association and Wells Fargo Bank, National Association valued at $1.5 billion (effective 2026-02-20).

“On February 20, 2026, as part of the Company’s existing stock repurchase program, the Company entered into accelerated share repurchase agreements (each, an “ASR Agreement” and together, the “ASR Agreements”) with each of HSBC Bank USA, National Association and Wells Fargo Bank, National Association (each, an “ASR Counterparty” and together, the “ASR Counterparties”) to repurchase an aggregate of $1.5 billion of the Company’s common stock, par value $0.001 per share (the “Common Stock”).”

Verisk Analytics, Inc. entered into Term Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto valued at $500,000,000 (effective 2026-02-18).

“On February 18, 2026, Verisk Analytics, Inc. (the “Company”) entered into a Term Credit Agreement (the “Term Credit Agreement”) among the Company, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent.”

SI-BONE, Inc. entered into Lease with Orchard Commons, LLC (effective 2026-02-20).

“On February 20, 2026, SI-BONE, Inc. (the “Company”) and Orchard Commons, LLC (the “Landlord”) entered into a lease agreement (the “Lease”), pursuant to which the Company will lease approximately 50,485 square feet of space located at 88 West Plumeria Drive, San Jose, California 95134 (the “Premises”).”

AMC Global Media Inc. amended First Supplemental Indenture with U.S. Bank Trust Company, National Association (effective 2026-02-23).

“On February 23, 2026, AMC Networks Inc. (“AMC Networks” or the “Company”), a Nevada corporation, certain of the Company’s subsidiaries (the “Guarantors”) and U.S. Bank Trust Company, National Association, as the trustee (the “Trustee”), entered into the First Supplemental Indenture (the “First Supplemental Indenture”) to the Indenture dated as of July 3, 2025 (the “Indenture”), between the Company, the Guarantors and the Trustee, under which the Company’s $400,000,000 aggregate principal amount of 10.50% Senior Secured Notes due 2032 (the “Notes”) were issued.”

Lument Finance Trust, Inc. amended Sixth Amendment to Credit and Guaranty Agreement with Cortland Capital Market Services LLC valued at incremental secured term loan of $2.25 million; maturity extended to February 20, 2030; interest rat (effective 2026-02-20).

“On February 20, 2026, the Company and the Guarantors entered into a further amendment (the “Sixth Amendment”) to the Credit and Guaranty Agreement (as so amended, the “Amended Credit and Guaranty Agreement”) with the Agent and the lenders party thereto, to, among other things: · provide the Company with an incremental secured term loan in the aggregate principal amount of $2.25 million (the “Second Incremental Secured Term Loan”), which the Company drew upon on February 23, 2026; · extend the maturity date of the secured term loans provided under the Amended Credit and Guaranty Agreement from February 20, 2026 to February 20, 2030.”

Lument Finance Trust, Inc. amended Fifth Amendment to Credit and Guaranty Agreement with Cortland Capital Market Services LLC valued at extended maturity date of secured term loans to February 20, 2026 (effective 2026-02-17).

“On February 17, 2026, Lument Finance Trust, Inc. (the “Company”), as borrower, and its subsidiaries, Five Oaks Acquisition Corp. and Lument CMT Equity, LLC, each as a guarantor (together, the “Guarantors”), Cortland Capital Market Services LLC, as the administrative agent and collateral agent (the “Agent”), and the lenders party thereto, entered into an amendment (the “Fifth Amendment”) to the Credit and Guaranty Agreement, dated January 15, 2019, as amended by each of the First Amendment to Credit and Guaranty Agreement, dated February 13, 2019, the Second Amendment to Credit and Guaranty Agreement, dated July 9, 2020, the Third Amendment to Credit and Guaranty Agreement, dated April 21, 2021, the Amended and Restated Third Amendment to Credit and Guaranty Agreement, dated August 23, 2021, and the Fourth Amendment to Credit and Guaranty Agreement, dated February 22, 2022 (collectively, and as further amended by the Fifth Amendment, the “Credit and Guaranty Agreement”).”

HA Sustainable Infrastructure Capital, Inc. entered into Senior Unsecured Notes Underwriting Agreement with the Underwriters (BofA Securities, Inc., Goldman Sachs & Co. LLC, Credit Agricole Securities (USA) Inc., Morgan Stanley & Co. LLC, Rabo Securities USA, Inc. and SMBC Nikko Securities America, Inc.) valued at $400,000,000 (effective 2026-02-19).

“On February 19, 2026 the Company and the Guarantors entered into an underwriting agreement (the “Senior Unsecured Notes Underwriting Agreement”) with the Underwriters, pursuant to which the Company agreed to issue and sell to the Underwriters $400,000,000 aggregate principal amount of its 6.000% Green Senior Unsecured Notes due 2036”

HA Sustainable Infrastructure Capital, Inc. entered into Junior Subordinated Notes Underwriting Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC, Credit Agricole Securities (USA) Inc., Morgan Stanley & Co. LLC, Rabo Securities USA, Inc. and SMBC Nikko Securities America, Inc., as representatives of the several underwriters valued at $600 million (effective 2026-02-18).

“On February 18, 2026, HA Sustainable Infrastructure Capital, Inc. (the “Company”) and the Guarantors (as defined below) entered into an underwriting agreement (the “Junior Subordinated Notes Underwriting Agreement”) with BofA Securities, Inc., Goldman Sachs & Co. LLC, Credit Agricole Securities (USA) Inc., Morgan Stanley & Co. LLC, Rabo Securities USA, Inc. and SMBC Nikko Securities America, Inc., as representatives of the several underwriters (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $600 million aggregate principal amount of its 7.125% Green Junior Subordinated Notes due 2056”

I-ON Digital Corp. entered into Agreements with five unrelated lenders valued at aggregate, principal amount of $1,210,00 plus all interest, penalties and fees (effective 2026-02-16).

“Commencing on February 16, 2026, I-On Digital Corporation (the “Company”) entered into settlement agreements (the “Agreements”) with five unrelated lenders to settle promissory notes (the “Notes”) in the aggregate, principal amount of $1,210,00 plus all interest, penalties and fees.”

Village Farms International, Inc. amended Amendment with Canadian Imperial Bank of Commerce valued at CAD $15 million (effective 2026-02-20).

“On February 20, 2026, Village Farms International, Inc. ("Village Farms" or “the Company”), amended its Canadian Cannabis credit facility with Canadian Imperial Bank of Commerce ("CIBC") (the "Amendment").”

Atara Biotherapeutics, Inc. amended Amendment with HCR Molag Fund, L.P. valued at $9.0 million (effective 2026-02-20).

“On February 20, 2026, Atara Biotherapeutics, Inc., (the “Company”) entered into an Amendment (the “Amendment”) to the Purchase and Sale Agreement dated as of December 20, 2022 (the “Agreement”) with HCR Molag Fund, L.P. (“HCR”). Under the terms of the Amendment, HCR agreed to amend the due date of the one-time of $9.0 million cash payment”

AVENUE THERAPEUTICS, INC. entered into License Agreement with Duke University (effective 2026-02-18).

“On February 18, 2026, Avenue Therapeutics, Inc. (the “Company”) entered into a license agreement (the “License Agreement”) with Duke University (“Duke”), whereby the Company obtained from Duke an exclusive, worldwide license to certain patents and know-how”

CNL Strategic Capital, LLC amended Amendment with Valley National Bank (effective 2026-02-23).

“On February 23, 2026, CNL Strategic Capital B, Inc. (“Borrower”), a wholly-owned subsidiary of CNL Strategic Capital, LLC ( the “Company”) and Valley National Bank, a Tennessee banking corporation, (referred to as “Valley National Bank”) entered into an Amendment (“Amendment”) to the Loan and Security Agreement (the “Loan Agreement”) previously entered into by such parties for a revolving line of credit (the “Line of Credit”).”

Vir Biotechnology, Inc. entered into Stock Purchase Agreement with Astellas US LLC valued at approximately $75 million (effective 2026-02-19).

“Concurrently with the execution of the Agreement, Vir Bio also entered into the SPA, pursuant to which Astellas has agreed to purchase 7,239,382 shares of Vir Bio’s common stock, par value $0.0001 per share (Common Stock), for an aggregate purchase price of approximately $75 million, subject to customary closing conditions.”

Vir Biotechnology, Inc. entered into Collaboration and License Agreement with Astellas US LLC valued at $335 million in upfront and near-term milestone payments (effective 2026-02-19).

“On February 19, 2026, Vir Biotechnology, Inc. (Vir Bio) and Astellas US LLC (together with its subsidiaries and affiliates (including its indirect parent, Astellas Pharma Inc.), Astellas) entered into a Collaboration and License Agreement (the Agreement).”

GameSquare Holdings, Inc. entered into Asset Purchase Agreement with Ben Group, Inc. and TubeBuddy, LLC as Seller (effective 2026-02-20).

“On February 20, 2026, GameSquare Holdings, Inc. (the “Company” or “Parent”), TubeBuddy, Inc., a Delaware corporation and indirect wholly-owned subsidiary of the Company (“Buyer”), Ben Group, Inc., a Nevada corporation (“Ben Group”), and TubeBuddy, LLC, a California limited liability company (“TB LLC”, and together with Ben Group, “Seller”), entered into an asset purchase agreement (the “Asset Purchase Agreement”),”

BrightSpire Capital, Inc. entered into Indenture with BRSP 2026-FL3 Ltd., BRSP 2026-FL3, LLC, BrightSpire Capital Advancing Agent, LLC, Wilmington Trust, National Association, Computershare Trust Company, National Association valued at Issuance of $544,350,000 Class A Notes, $102,662,000 Class A-S Notes, $60,881,000 Class B Notes, $59 (effective 2026-02-17).

“On February 17, 2026 (the “CLO Closing Date”), BrightSpire Capital, Inc. (the “Company”) entered into a collateralized loan obligation (the “CLO”) through its subsidiary real estate investment trust, BrightSpire Capital Mortgage Sub-REIT, LLC (“Sub-REIT”), and two wholly-owned subsidiaries of Sub-REIT, BRSP 2026-FL3 Ltd., a newly formed exempted company incorporated with limited liability under the laws of the Cayman Islands, as issuer (the “Issuer”), and BRSP 2026-FL3, LLC, a Delaware limited liability company, as co-issuer (the “Co-Issuer” and together with the Issuer, the “CLO Issuers”).”

TRANSUITE.ORG INC. entered into Cooperation Agreement with Honwo Technology Holding Limited (effective 2026-02-21).

“On February 21, 2026, Transuite.org Inc. (the “Company” or “TRSO”) entered into a Cooperation Agreement (the “Agreement”) with Honwo Technology Holding Limited (“Honwo”) to establish a long-term Web3 technology and business collaboration framework.”

ADC Therapeutics SA amended Amendment with entities managed by HealthCare Royalty Management, LLC (effective 2026-02-18).

“On February 18, 2026, ADC Therapeutics SA (the “Company”) entered into an amendment (the “Amendment”) to the Purchase and Sale Agreement, dated August 25, 2021 (the “Original Agreement” and, as amended by the Amendment, the “Amended Agreement”), among the Company and entities managed by HealthCare Royalty Management, LLC (“HCR”).”

Interactive Strength, Inc. entered into Agreement and Plan of Merger with Ergatta, Inc. (effective 2026-02-18).

“On February 18, 2026, Interactive Strength Inc. (the "Company") entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Ergatta, Inc., a Delaware corporation ("Ergatta"), Ergatta Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"), and Tom Aulet, solely in his capacity as the securityholders’ representative (the “Securityholders’ Representative”), pursuant to which Merger Sub will merge with and into Ergatta (the “Merger”), with Ergatta surviving as a wholly owned subsidiary of the Company.”

Arcellx, Inc. entered into Agreement and Plan of Merger with Gilead Sciences, Inc. (effective 2026-02-22).

“On February 22, 2026, Arcellx, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Gilead Sciences, Inc., a Delaware corporation (“ Parent ”), and Ravens Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”).”

Ovintiv Inc. entered into Purchase and Sale Agreement with MidCon II BuyerCo, LLC valued at $3.0 billion (effective 2026-02-17).

“On February 17, 2026, Ovintiv USA Inc. and Ovintiv Royalty Holdings LLC (together, the “Seller”), each a wholly-owned subsidiary of Ovintiv Inc. (“Ovintiv”), entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with MidCon II BuyerCo, LLC (the “Buyer”), pursuant to which Seller has agreed to sell certain of Ovintiv’s oil and gas assets located in Oklahoma (the “Assets”) to Buyer through Buyer’s acquisition of all the issued and outstanding equity interests (the “Target Company Securities”) of a newly formed Texas limited liability company (“Target Company”).”

NEXTNRG, INC. entered into Stock Purchase Agreement with an investor (the "Purchaser") valued at $100,000 (effective 2026-02-18).

“On February 18, 2026, NextNRG, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “February 18 SPA”) with an investor (the “Purchaser”). Pursuant to the terms of the February 18 SPA, the Company agreed to sell, and the Purchaser agreed to purchase, 133,333 shares of the Company’s common stock at a purchase price of $100,000, representing a price per share of $0.75.”

MoonLake Immunotherapeutics amended First Amendment to Loan and Security Agreement (Amended Loan and Security Agreement) with Hercules Capital, Inc. valued at Up to $400.0 million of potential future funding; aggregate principal amount of $500.0 million acros (effective 2026-02-20).

“On February 20, 2026 (the "Amendment Closing Date"), MoonLake Immunotherapeutics (the "Company"), as a guarantor, entered into a first amendment to loan and security agreement (the loan and security agreement, as so amended, the "Amended Loan and Security Agreement") with its subsidiary, MoonLake Immunotherapeutics AG, as borrower, the other guarantors party thereto, the lenders party thereto (the "Lenders"), and Hercules Capital, Inc., as the administrative agent and collateral agent (the "Agent") for itself and the Lenders, pursuant to which the parties agreed to amend the loan and security agreement dated March 31, 2025 to, among other things, modify the available tranches, milestone dates and financial covenants.”

Barinthus Biotherapeutics plc. amended Amendment to the Agreement and Plan of Merger with Clywedog Therapeutics, Inc. valued at Amendment to exchange ratios and minimum cash requirements in connection with scheme of arrangement (effective 2026-02-22).

“On February 22, 2026, the Beacon, Topco, Merger Sub and Clywedog entered into the Amendment to the Agreement and Plan of Merger”

Better Home & Finance Holding Co entered into Securities Purchase Agreement with Framework Ventures IV L.P. valued at $0.01 (effective 2026-02-17).

“On February 17, 2026, Better Home & Finance Holding Company (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Framework Ventures IV L.P. (“Purchaser”).”

VEEA INC. entered into Loan Agreement with Pasadena Private Lending, Inc. valued at $10,550,000 (effective 2026-02-17).

“On February 17, 2026, VeeaSystems Inc., a Delaware Corporation (the “ Borrower ”) and a wholly owned subsidiary of Veea Inc. (the “ Company ”), entered into a Loan Agreement (the “ Loan Agreement ”) with Pasadena Private Lending, Inc. (the “ Lender ”), pursuant to which the Lender has agreed to extend, on the terms provided in the Loan Agreement, a secured term loan facility to the Borrower in an aggregate principal amount of up to $10,550,000.”

Candel Therapeutics, Inc. entered into Underwriting Agreement with Citigroup Global Markets Inc., Cantor Fitzgerald & Co., and Stifel, Nicolaus & Company, Incorporated valued at approximately $93.5 million (effective 2026-02-19).

“On February 19, 2026, Candel Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., Cantor Fitzgerald & Co., and Stifel, Nicolaus & Company, Incorporated, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of 18,348,624 shares (the “Firm Shares”) of its common stock, par value $0.01 per share (the “Common Stock”), at a price to the public of $5.45 per share (the “Offering”).”

Twin Vee PowerCats, Co. entered into Placement Agency Agreement with ThinkEquity LLC valued at aggregate gross proceeds of approximately $3.0 million (effective 2026-02-19).

“On February 19, 2026, Twin Vee PowerCats Co., a Delaware corporation (the “Company”), entered into a placement agency agreement (the “Placement Agency Agreement”) with ThinkEquity LLC, as sole placement agent (the “Placement Agent”), pursuant to which the Company agreed to issue and sell directly to various investors in a best efforts public offering (the “Offering”) an aggregate of 6,383,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a public offering price of $0.47 per share.”

Angel Studios, Inc. amended Ratification and First Amendment to Loan and Security Agreement with Trinity Capital Inc., as agent for the lenders (effective 2025-09-09).

“On February 17, 2026, Angel Studios, Inc., a Delaware corporation (the “Company”), and certain of the Company’s subsidiaries entered into a Ratification and First Amendment to Loan and Security Agreement, effective as of September 9, 2025 (the “First Credit Facility Amendment”), which amended the Loan and Security Agreement (the “Credit Facility”), dated as of September 8, 2025, by and among Angel Studios Legacy, Inc. (f/k/a Angel Studios, Inc.), a Delaware corporation (the “Original Borrower”), and certain of the Original Borrower’s subsidiaries, certain lenders thereunder, and Trinity Capital Inc., a Maryland corporation, as agent for the lenders (“Administrative Agent”).”

Goldman Sachs Private Credit Corp. entered into Registration Rights Agreements with BofA Securities, Inc. valued at Registration rights agreements for New 2031 Notes and 2028 Notes (effective 2026-02-23).

“In connection with the Notes Offering, the Company entered into (i) a Registration Rights Agreement, dated as of February 23, 2026, with BofA Securities, Inc., as the representative of the initial purchasers of the New 2031 Notes (the “2031 Notes Registration Rights Agreement”) and (ii) a Registration Rights Agreement, dated as of February 23, 2026, with BofA Securities, Inc., as the representative of the initial purchasers of the 2028 Notes (the “2028 Notes Registration Rights Agreement” and, together with the 2031 Notes Registration Rights Agreement, the “Registration Rights Agreements”).”

Goldman Sachs Private Credit Corp. entered into Fifth Supplemental Indenture (2028 Notes Indenture) with The Trustee valued at $700,000,000 aggregate principal amount of 5.050% notes due 2028 (effective 2026-02-23).

“On February 23, 2026, the Company and the Trustee entered into a fifth supplemental indenture (the “Fifth Supplemental Indenture” and, together with the Base Indenture, the “2028 Notes Indenture”; the 2031 Notes Indenture and the 2028 Notes Indenture, the “Indentures” and each an “Indenture”) supplementing the Base Indenture and relating to the Company’s issuance of $700,000,000 aggregate principal amount of its 5.050% notes due 2028 (the “2028 Notes” and, together with the New 2031 Notes, the “Notes”).”

Goldman Sachs Private Credit Corp. entered into Indentures with The Trustee valued at $1,100,000,000 aggregate principal amount of notes (comprising $400,000,000 New 2031 Notes at 5.875% (effective 2026-02-23).

“On February 23, 2026, Goldman Sachs Private Credit Corp. (the “Company”, “we” or “our”) issued $400,000,000 aggregate principal amount of its 5.875% Notes due 2031 (the “New 2031 Notes”) under the Company’s indenture dated as of May 6, 2025 (the “Base Indenture”) and fourth supplemental indenture, dated as of November 24, 2025 (together with the Base Indenture, the “2031 Notes Indenture”).”

VisionWave Holdings, Inc. entered into Loan Agreement with C.M. Composite Materials Ltd. valued at $5,000,000 (effective 2026-02-20).

“(ii) a Loan Agreement (the “Loan Agreement”), dated as of February 20, 2026, by and between the Company (as Lender) and the Target Company (as Borrower).”

VisionWave Holdings, Inc. entered into Investment and Share Purchase Agreement with C.M. Composite Materials Ltd. and Matania (Mati) Moskovich valued at $2,500,000 (effective 2026-02-20).

“On February 20, 2026 (the “Effective Date”), VisionWave Holdings, Inc., a Delaware corporation (the “Company”), entered into two related definitive agreements in connection with a strategic investment and acquisition transaction involving C.M. Composite Materials Ltd., an Israeli corporation with registration number 513931980 (the “Target Company”): (i) an Investment and Share Purchase Agreement (the “Share Purchase Agreement”), dated as of February 20, 2026, by and among the Company (as Buyer), Matania (Mati) Moskovich (as Seller), and the Target Company (solely for purposes of acknowledgment and certain covenants);”

Resolute Holdings Management, Inc. terminated Existing Credit Agreement with JPMorgan Chase Bank, N.A. valued at $5 million (effective 2026-02-20).

“The information set forth in Item 1.01 regarding the termination of the Existing Credit Agreement is incorporated by reference herein.”

Resolute Holdings Management, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $30 million (effective 2026-02-20).

“On February 20, 2026, Resolute Holdings Management, Inc. (“Resolute” or the “Company”), the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (“JPMC”) entered into a new Credit Agreement (the “Credit Agreement”) to replace the Company’s existing $5 million senior secured revolving facility under that certain Credit Agreement, dated as of February 28, 2025, by and between the Company and JPMC (the “Existing Credit Agreement”), with an upsized $30 million senior secured revolving credit facility maturing on February 20, 2031.”

Real Asset Acquisition Corp. entered into Business Combination Agreement with IQM Finland Oy, IQM US LLC, Eclipse QC S.à r.l. valued at Business combination agreement providing for merger of RAAQ with Merger Sub (effective 2026-02-22).

“On February 22, 2026, Real Asset Acquisition Corp., a Cayman Islands exempted company (“RAAQ”), IQM Finland Oy, a limited liability company (Fi. osakeyhtiö ) incorporated under the laws of Finland (“IQM”), IQM US LLC, a Delaware limited liability company and an indirect wholly owned subsidiary of IQM (“Merger Sub”), and Eclipse QC S.à r.l., a Luxembourg private limited liability company ( société à responsabilité limitée ) and a direct wholly owned subsidiary of IQM (“LuxCo,” collectively with Merger Sub, the “Merger Subs”) entered into a business combination agreement (the “Business Combination Agreement”).”

Invest Green Acquisition Corp entered into Unsecured Promissory Note with IG SPAC Sponsor LLC valued at $3,500,000 (effective 2025-12-01).

“On February 17, 2026, Invest Green Acquisition Corporation (the “Company”) issued an unsecured promissory note in the aggregate principal amount of $3,500,000 (the “Note”) to IG SPAC Sponsor LLC (“Sponsor”) that is effective as of December 1, 2025.”

Armada Acquisition Corp. III entered into Northland Private Placement Purchase Agreement with Northland Securities, Inc. (effective 2026-02-17).

“a Private Placement Unit Subscription Agreement, dated February 17, 2026 (the “Northland Private Placement Purchase Agreement””

Armada Acquisition Corp. III entered into CCM Private Placement Purchase Agreement with Cohen & Company Capital Markets, LLC (effective 2026-02-17).

“a Private Placement Unit Subscription Agreement, dated February 17, 2026 (the “CCM Private Placement Purchase Agreement”), by and between the Company and CCM”

Armada Acquisition Corp. III entered into Sponsor Private Placement Purchase Agreement with Armada Sponsor III LLC (effective 2026-02-17).

“a Private Placement Unit Subscription Agreement, dated February 17, 2026 (the “Sponsor Private Placement Purchase Agreement”), by and between the Company and Armada Sponsor III LLC (the “Sponsor”)”

Armada Acquisition Corp. III entered into Underwriting Agreement with Cohen & Company Capital Markets, LLC and Northland Securities, Inc., as representatives of the several underwriters (effective 2026-02-17).

“an Underwriting Agreement, dated February 17, 2026, by and among the Company and Cohen & Company Capital Markets, a division of Cohen & Company Capital Markets, LLC (“CCM”), and Northland Securities, Inc. (“Northland”), as representatives (the “Representatives”) of the several underwriters named therein”

ILLINOIS TOOL WORKS INC terminated Credit Agreement with the lenders named therein, and JPMorgan Chase Bank, N.A., as Agent (effective 2026-02-20).

“On February 20, 2026, in connection with the Company’s entry into the Credit Agreement, the existing credit agreement dated October 21, 2022, as amended, by and among the Company, the lenders named therein, and JPMorgan Chase Bank, N.A., as Agent, was terminated.”

ILLINOIS TOOL WORKS INC entered into Credit Agreement with JPMorgan Chase Bank, N.A., as Agent, Citibank, N.A. as Syndication Agent, and a syndicate of lenders valued at $3.0 billion (effective 2026-02-20).

“On February 20, 2026, Illinois Tool Works Inc. (the “Company”) entered into a $3.0 billion, five-year credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as Agent, Citibank, N.A. as Syndication Agent, both of which served as Joint Lead Arrangers and Joint Bookrunners, and a syndicate of lenders”

TCW STRATEGIC INCOME FUND INC entered into Dealer Manager Agreement with UBS Securities LLC (effective 2026-02-19).

“On February 19, 2026, TCW Strategic Income Fund, Inc. (NYSE: TSI) (the “Fund”) entered into a dealer manager agreement (the “Dealer Manager Agreement”) by and among the Fund, TCW Investment Management Company LLC and UBS Securities LLC”